Literature DB >> 8187810

Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction.

H Giles1, R E Smith, J F Martin.   

Abstract

Platelet aggregation, which plays an important role in acute myocardial infarction (AMI), is mediated by fibrinogen binding to the platelet membrane glycoprotein (GP)IIb-IIIa (CD41). This study measured the relative number of GPIIb-IIIa complexes on platelets from patients immediately following AMI (n = 14) compared with those from controls (n = 14). Flow cytometry was used to demonstrate that there were, on average, 20% more GPIIb-IIIa complexes on platelets after AMI compared with controls. Platelet size was also 7% greater in AMI and it is known that larger platelets are more reactive. Since platelet size and protein content are determined at thrombopoiesis the majority of these platelets must have been circulating prior to AMI. Larger platelets, with more GPIIb-IIIa may, therefore, be causally related to AMI.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8187810     DOI: 10.1111/j.1365-2362.1994.tb02062.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  49 in total

Review 1.  Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.

Authors:  C M Gibson; J L Moynihan; E N Al-Mousa; M Campsey; R Gandhi; S Murphy; S Mattson; K A Ryan; R Mesley; J Swanson; M N Arshad; S J Marble
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

2.  Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Murat Sezer; Irem Okcular; Taner Goren; Huseyin Oflaz; Yilmaz Nisanci; Berrin Umman; Fehmi Mercanoglu; Ahmet K Bilge; Mehmet Meric; Sabahattin Umman
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

3.  Serial clopidogrel dose adjustment after platelet function testing improves outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention with high on-treatment platelet reactivity.

Authors:  Jure Samardzic; Miroslav Krpan; Bosko Skoric; Marijan Pasalic; Mate Petricevic; Davor Milicic
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

4.  Mean platelet volume: is it a predictive parameter in diagnosis of acute mesenteric ischemia?

Authors:  Ahmet Türkoğlu; Mesut Gül; Abdullah Oğuz; Zübeyir Bozdağ; Burak Veli Ülger; Ahmet Yılmaz; Mustafa Aldemir
Journal:  Int Surg       Date:  2015-05

5.  Mean platelet volume: ready for prime time?

Authors:  Tomás Benito-González; Rodrigo Estévez-Loureiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Does the mean platelet volume have any importance in patients with acute pulmonary embolism?

Authors:  Ermis Hilal; Yucel Neslihan; Gulbas Gazi; Turkkan Sinan; Aytemur Zeynep Ayfer
Journal:  Wien Klin Wochenschr       Date:  2013-06-27       Impact factor: 1.704

7.  Mean platelet volume and mortality risk in a national incident hemodialysis cohort.

Authors:  Steven Kim; Miklos Z Molnar; Gregg C Fonarow; Elani Streja; Jiaxi Wang; Daniel L Gillen; Rajnish Mehrotra; Steven M Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Connie M Rhee
Journal:  Int J Cardiol       Date:  2016-06-23       Impact factor: 4.164

Review 8.  Biomarkers in acute coronary artery disease.

Authors:  Matthias K Freynhofer; Miloš Tajsić; Johann Wojta; Kurt Huber
Journal:  Wien Med Wochenschr       Date:  2012-11-10

Review 9.  Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.

Authors:  S G Chu; R C Becker; P B Berger; D L Bhatt; J W Eikelboom; B Konkle; E R Mohler; M P Reilly; J S Berger
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

10.  Mean platelet volume as a predictor for long-term outcome after percutaneous coronary intervention.

Authors:  Alon Eisen; Tamir Bental; Abid Assali; Ran Kornowski; Eli I Lev
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.